Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study

TREND Study Group

89 Citations (Scopus)
10 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Treat-and-Extend versus Monthly Regimen in Neovascular Age-Related Macular Degeneration: Results with Ranibizumab from the TREND Study'. Together they form a unique fingerprint.

Medicine & Life Sciences